Thursday, July 21, 2022 6:38:52 AM
- Heavy drinkers are the biggest group and in practice are those that get help and treatment more than the very heavy drinkers. Very heavy drinkers have a stronger physiologic addiction and are more in denial.
- Stat. Sig. in heavy drinkers (0.003) is super for a near 90% response. Splitting groups (heavy and very heavy drinkers) is allowed. It is overly clear that the very heavy drinkers placebo group had a strong placebo effect and started to drink less. So there is no reasons that groups could not be split.
- AUD has currently no strongly approved treatment (unmet need)
- The market is huge, which makes me think that a BP could make an offer on this (low amount of outstanding shares, low price, this is pocket money and for ADIL it would be bingo. win-win)
- ADIL PPS is mainly down because the play-press like the fool titled the trial as a failure and did not emphasize the value of the only group of interest: heavy drinkers (but what else is new). Created a perfect window of opportunity to get in low (below 2$).
- Management brings these results to US/European regulators and this looks like the best thing around for treatment of AUD. In all cases, and no matter the 0.007 stat. sig. if very heavy and heavy drinkers are joined, this still is better than whatever is out there now.
Note there is no real SOC (Standard of Care) for this, the best those AUD patients can get is some drug that has been approved for something else ( a neural condition) that probably (speculation) does them more harm then good.
I wanted to have this stock now (bought it at 1.49$ posting (HERE) that I expected it to go down even more because I placed a large AON order, and AON orders tend to have that effect).
The reason that I want it now, knowing that any regulators procedure will take at least 24 months is that I suspect that some BP will see the huge market and may be willing to place money in this because with the results at hand, doing a new heavy drinkers only clinical trial is nothing for BP. They up the participants and do the test way faster then anybody else, certainly with the current results to convince dockers in treatment centers.
So I want to be onboard now, because a thing like that happens WITHOUT any warning.
And for those of you that are in at even higher prices, 'don't panic' :)
AIMO
PS: I post mostly on the CDMO board here on IHUB because I follow things in depth and do not trade anymore (occasionally I do a trade, but mostly invest). I look at ADIL as an investment.
All In My Opinion. I am not advising anything, nor accusing anyone.
Recent ADIL News
- Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office • GlobeNewswire Inc. • 04/22/2024 12:30:00 PM
- Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder • GlobeNewswire Inc. • 04/10/2024 12:30:00 PM
- Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
- Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds • GlobeNewswire Inc. • 03/02/2024 12:00:00 AM
- Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office • GlobeNewswire Inc. • 02/28/2024 02:30:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:22:13 PM
- Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office • GlobeNewswire Inc. • 02/13/2024 02:15:24 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/25/2024 09:30:56 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/25/2024 05:15:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:15:23 PM
- Adial Announces Appointment of Tony Goodman as Chief Operating Officer • GlobeNewswire Inc. • 01/18/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:17:10 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/12/2024 09:51:29 PM
- Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate • GlobeNewswire Inc. • 12/20/2023 02:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/12/2023 09:36:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/08/2023 04:08:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:47:52 PM
- Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement • GlobeNewswire Inc. • 11/29/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:10:09 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/24/2023 02:24:17 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/20/2023 12:46:55 PM
- Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 10:02:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/08/2023 09:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 11:14:31 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM